Fidelity Advisor Freedom 2020 Fund
Name
As of 03/26/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
3.1%
1 yr return
12.2%
3 Yr Avg Return
0.9%
5 Yr Avg Return
5.4%
Net Assets
$1.29 B
Holdings in Top 10
71.6%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.82%
SALES FEES
Front Load 5.75%
Deferred Load N/A
TRADING FEES
Turnover 34.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 03/26/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
FDAFX - Profile
Distributions
- YTD Total Return 3.1%
- 3 Yr Annualized Total Return 0.9%
- 5 Yr Annualized Total Return 5.4%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio 2.02%
- Dividend Yield 3.9%
- Dividend Distribution Frequency SemiAnnual
Fund Details
-
Legal NameFidelity Advisor Freedom 2020 Fund
-
Fund Family NameFidelity Group of Funds
-
Inception DateJul 25, 2003
-
Shares OutstandingN/A
-
Share ClassA
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerAndrew Dierdorf
Fund Description
FDAFX - Performance
Return Ranking - Trailing
Period | FDAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 3.1% | 1.2% | 6.6% | 39.42% |
1 Yr | 12.2% | 4.8% | 15.8% | 40.88% |
3 Yr | 0.9%* | -1.1% | 4.4% | 79.55% |
5 Yr | 5.4%* | 1.7% | 7.4% | 50.42% |
10 Yr | 5.4%* | 3.3% | 6.5% | 45.90% |
* Annualized
Return Ranking - Calendar
Period | FDAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 9.7% | 3.8% | 11.5% | 19.12% |
2022 | -22.9% | -32.2% | -12.0% | 81.62% |
2021 | -2.3% | -9.5% | 12.0% | 81.10% |
2020 | 5.0% | -12.1% | 12.6% | 77.78% |
2019 | 10.8% | -0.2% | 15.3% | 59.32% |
Total Return Ranking - Trailing
Period | FDAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 3.1% | 1.2% | 6.6% | 39.42% |
1 Yr | 12.2% | 4.8% | 15.8% | 40.88% |
3 Yr | 0.9%* | -1.1% | 4.4% | 79.55% |
5 Yr | 5.4%* | 1.7% | 7.4% | 50.42% |
10 Yr | 5.4%* | 3.3% | 6.5% | 45.90% |
* Annualized
Total Return Ranking - Calendar
Period | FDAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 12.1% | 7.6% | 15.6% | 53.68% |
2022 | -16.3% | -23.3% | -11.0% | 85.29% |
2021 | 8.3% | 4.1% | 16.5% | 66.93% |
2020 | 13.0% | -6.0% | 16.1% | 28.57% |
2019 | 18.4% | 12.6% | 21.7% | 22.88% |
NAV & Total Return History
FDAFX - Holdings
Concentration Analysis
FDAFX | Category Low | Category High | FDAFX % Rank | |
---|---|---|---|---|
Net Assets | 1.29 B | 4.02 M | 37.8 B | 37.96% |
Number of Holdings | 46 | 7 | 577 | 16.79% |
Net Assets in Top 10 | 956 M | 2.07 M | 39 B | 37.96% |
Weighting of Top 10 | 71.57% | 52.1% | 100.3% | 64.96% |
Top 10 Holdings
- Fidelity Series Investment Grade Bond Fund 28.20%
- Fidelity Series 5+ Year Inflation-Protected Bond Index Fund 7.69%
- Fidelity Series Emerging Markets Opportunities Fund 7.04%
- Fidelity Series Large Cap Stock Fund 4.55%
- Fidelity Series Long-Term Treasury Bond Index Fund 4.52%
- Fidelity Series International Growth Fund 4.15%
- Fidelity Series Overseas Fund 4.13%
- Fidelity Series International Value Fund 4.08%
- Fidelity Series International Developed Markets Bond Index Fund 3.83%
- Fidelity Advisor Series Equity Growth Fund 3.37%
Asset Allocation
Weighting | Return Low | Return High | FDAFX % Rank | |
---|---|---|---|---|
Stocks | 99.50% | 0.00% | 100.11% | 49.64% |
Convertible Bonds | 0.57% | 0.00% | 1.38% | 53.28% |
Cash | 0.25% | 0.00% | 35.78% | 53.28% |
Bonds | 0.18% | 0.00% | 75.85% | 27.74% |
Other | 0.11% | -0.06% | 3.96% | 16.79% |
Preferred Stocks | 0.00% | 0.00% | 0.04% | 90.51% |
Stock Sector Breakdown
Weighting | Return Low | Return High | FDAFX % Rank | |
---|---|---|---|---|
Financial Services | 19.15% | 12.26% | 19.15% | 4.38% |
Technology | 17.27% | 13.94% | 23.92% | 72.99% |
Healthcare | 11.86% | 10.66% | 15.12% | 74.45% |
Industrials | 11.63% | 8.53% | 12.76% | 25.55% |
Consumer Cyclical | 9.38% | 7.73% | 13.31% | 83.94% |
Communication Services | 7.57% | 5.56% | 9.97% | 28.47% |
Basic Materials | 7.16% | 3.04% | 7.27% | 12.41% |
Energy | 6.23% | 2.44% | 8.11% | 13.14% |
Consumer Defense | 5.56% | 4.92% | 10.96% | 89.05% |
Utilities | 2.21% | 1.91% | 7.99% | 94.89% |
Real Estate | 1.98% | 1.87% | 16.02% | 96.35% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | FDAFX % Rank | |
---|---|---|---|---|
US | 99.50% | 0.00% | 100.11% | 49.64% |
Non US | 0.00% | 0.00% | 13.95% | 94.16% |
Bond Sector Breakdown
Weighting | Return Low | Return High | FDAFX % Rank | |
---|---|---|---|---|
Government | 49.45% | 21.49% | 99.39% | 40.88% |
Corporate | 18.58% | 0.01% | 46.14% | 74.45% |
Securitized | 14.42% | 0.00% | 30.82% | 68.61% |
Municipal | 0.37% | 0.00% | 1.32% | 24.82% |
Cash & Equivalents | 0.25% | 0.00% | 62.69% | 52.55% |
Derivative | 0.11% | -0.06% | 0.11% | 6.57% |
Bond Geographic Breakdown
Weighting | Return Low | Return High | FDAFX % Rank | |
---|---|---|---|---|
US | 0.18% | 0.00% | 75.85% | 27.74% |
Non US | 0.00% | 0.00% | 2.00% | 90.51% |
FDAFX - Expenses
Operational Fees
FDAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.82% | 0.06% | 24.24% | 39.71% |
Management Fee | 0.57% | 0.00% | 0.61% | 95.59% |
12b-1 Fee | 0.25% | 0.00% | 1.00% | 60.00% |
Administrative Fee | N/A | 0.01% | 0.28% | N/A |
Sales Fees
FDAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | 5.75% | 3.50% | 5.75% | 30.77% |
Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
FDAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | N/A | N/A | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
FDAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 34.00% | 5.00% | 137.00% | 54.62% |
FDAFX - Distributions
Dividend Yield Analysis
FDAFX | Category Low | Category High | FDAFX % Rank | |
---|---|---|---|---|
Dividend Yield | 3.89% | 0.00% | 6.98% | 86.86% |
Dividend Distribution Analysis
FDAFX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | SemiAnnual | Annual | Quarterly | SemiAnnual |
Net Income Ratio Analysis
FDAFX | Category Low | Category High | FDAFX % Rank | |
---|---|---|---|---|
Net Income Ratio | 2.02% | 0.16% | 3.78% | 26.12% |
Capital Gain Distribution Analysis
FDAFX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Semi-Annually | Annually | Semi-Monthly | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Dec 29, 2023 | $0.242 | OrdinaryDividend |
May 15, 2023 | $0.006 | OrdinaryDividend |
Dec 30, 2022 | $0.294 | OrdinaryDividend |
May 15, 2017 | $0.023 | OrdinaryDividend |
May 07, 2012 | $0.024 | OrdinaryDividend |
Dec 30, 2011 | $0.159 | OrdinaryDividend |
May 09, 2011 | $0.019 | OrdinaryDividend |
Dec 31, 2010 | $0.145 | OrdinaryDividend |
May 10, 2010 | $0.024 | OrdinaryDividend |
Dec 29, 2009 | $0.162 | OrdinaryDividend |
May 18, 2009 | $0.027 | OrdinaryDividend |
Dec 29, 2008 | $0.213 | OrdinaryDividend |
May 12, 2008 | $0.038 | OrdinaryDividend |
Dec 31, 2007 | $0.223 | OrdinaryDividend |
May 07, 2007 | $0.027 | OrdinaryDividend |
Dec 29, 2006 | $0.196 | OrdinaryDividend |
May 08, 2006 | $0.029 | OrdinaryDividend |
Dec 30, 2005 | $0.144 | OrdinaryDividend |
May 09, 2005 | $0.014 | OrdinaryDividend |
Dec 30, 2004 | $0.160 | OrdinaryDividend |
May 10, 2004 | $0.021 | OrdinaryDividend |
Dec 29, 2003 | $0.085 | OrdinaryDividend |
FDAFX - Fund Manager Analysis
Managers
Andrew Dierdorf
Start Date
Tenure
Tenure Rank
Jun 30, 2011
10.93
10.9%
Andrew Dierdorf is co-manager of each fund, which he has managed since October 2009 (other than Fidelity Freedom® Index 2055 Fund, Fidelity Freedom® Index 2060 Fund, and Fidelity Freedom® Index 2065 Fund). He has managed Fidelity Freedom® Index 2055 Fund since June 2011, Fidelity Freedom® Index 2060 Fund since August 2014, and Fidelity Freedom® Index 2065 Fund since June 2019. He also manages other funds. Since joining Fidelity Investments in 2004, Mr. Dierdorf has worked as a portfolio manager.
Brett Sumsion
Start Date
Tenure
Tenure Rank
Jan 21, 2014
8.36
8.4%
Brett Sumsion is co-manager of each fund, which he has managed since January 2014 (other than Fidelity Freedom® Index 2060 Fund and Fidelity Freedom® Index 2065 Fund). He has managed Fidelity Freedom® Index 2060 Fund since August 2014 and Fidelity Freedom® Index 2065 Fund since June 2019. He also manages other funds. Since joining Fidelity Investments in 2014, Mr. Sumsion has worked as a portfolio manager. Mr. Sumsion earned his bachelor of arts degree from Brigham Young University and his MBA from The Wharton School at the University of Pennsylvania. He is a CFA charterholder.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.08 | 16.18 | 5.96 | 2.41 |